Tandem Diabetes Care Launches t:slim X2 Insulin Pump with Control-IQ Technology
Posted on January 16, 2020 by Medtech[y] Staff
Tandem Diabetes Care (NASDAQ: TNDM) announced the commercial launch of their new t:slim X2 insulin pump with Control-IQ technology, which helps stabilize blood sugar levels with the help of an automated insulin dosing system.
The system is the first on the market to deliver automatic correction boluses in addition to adjusting insulin to help prevent high and low blood sugar.
“Control-IQ technology has been described by study participants and investigators as ‘life-changing,’ ‘easy to use,’ and ‘a new standard of care in insulin therapy management,’ which is incredible feedback as we commence this commercial launch and begin bringing its benefits to more people with diabetes,” said John Sheridan, President and Chief Executive Officer. “We began processing orders earlier this month and are excited about the opportunity this launch presents for 2020. As these new customers move through the insurance verification process it will provide us with valuable trend information that will be used in setting our financial guidance for the year.”
Additionally, the system integrates with Dexcom G6 continuous glucose monitoring (CGM), which requires no fingersticks for calibration or diabetes treatment decisions.